Biotech InventisBio Announces Positive Phase 2 Study Results for D-2570 (TYK2 Inhibitor) in Patients with Moderate to Severe Plaque Psoriasis December 3, 2024
Biotech Patrik Tolf steps down as CFO of the Vitrolife Group – Helena Wennerström appointed acting CFO December 3, 2024
Biotech Sparsentan receives Orphan Drug Designation for primary IgA nephropathy in Japan December 2, 2024
Biotech Bioinformatics Market to Grow by USD 13.2 Billion (2024-2028), Lower Genetic Sequencing Costs Drive Revenue, Report Highlights AI’s Role in Transformation – Technavio November 30, 2024
Biotech CBC Group Completes Strategic Acquisition of UCB’s Mature Product Portfolio in China November 30, 2024
Biotech Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline November 29, 2024
Biotech Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight November 29, 2024
Biotech Akeso to Present at Citi 2024 Global Healthcare Conference and the 7th Annual Evercore HealthCONx Conference November 29, 2024
Biotech Myotonic Dystrophy Clinical Trial Pipeline Boom as Over 20 Companies Leading the Charge in Research and Development | DelveInsight November 28, 2024